ALX ONCOLOGY HOLDINGS INC
ALXO · Pharmaceutical Preparations · 134.6M shares · +32%/yr ↑ dilution · EDGAR filings ↗
Net buyback after stock comp: -$26M (gross $6K, SBC $26M)
Reference price $2.17 · est. market cap ~$292M — last insider sale, 2026-03-19 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)
Grade
D42Clinical/early-stage biotech — immuno-oncology clinical, heavy burn ($84M), funded.
Strengths
- Liquidity — current ratio 2.1 (27th)
Risks
- Pre-revenue, deep losses — per metrics
- Pre-revenue/clinical-stage — history of losses & need for capital per risk factors
- Binary clinical & funding risk — per 10-K
Notable findings
- No interest coverageInterest coverage -64.93 (cannot cover interest)
- Cash burnNegative free cash flow (-84.4M)
- Chronic dilutionShare count +32%/yr over 3y (dilution, book value/share -96%)
- Fund exitedNotable fund(s) exited this quarter: VANGUARD GROUP INC
- Exec changeRecent 8-K item 5.02 8-K ↗
- Insider buyingInsider buying — 1 open-market buy(s) by 1 insider(s) (~$5M, last 6mo) Form 4 ↗
- Notable holderHeld by 5 notable fund(s): RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, GOLDMAN SACHS GROUP INC +2 more (as of 2026-03-31)
- Insider sellingInsider selling — 4 open-market sale(s) by 2 insider(s) (cluster of 2 insiders, last 6mo) Form 4 ↗
Quarterly revenue
Last 4 quarters · from SEC filings.
Key metrics
Return on equity
-391.4%
Return on assets
-172.2%
ROIC
-269.3%
Debt / equity
0.2×
Interest coverage
-64.9×
Current ratio
2.1×
Free cash flow
-$84M
EBITDA
-$103M
Tangible book value
$26M
Cash & investments
$48M
Cash runway
2q
Insider transactions · last 18 months
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-03-19 | Pinto Shelly | Sell | 903 | $2.17 |
| 2026-03-19 | Lettmann Jason | Sell | 12K | $2.17 |
| 2026-02-18 | Pinto Shelly | Sell | 565 | $2.27 |
| 2026-02-17 | Lettmann Jason | Tax withheld | 2.2K | $2.27 |
| 2026-02-02 | GOODMAN COREY S | Buy | 3.2M | $1.57 |
| 2026-01-06 | Pinto Shelly | Sell | 3.9K | $1.11 |
| 2025-09-17 | Lettmann Jason | Buy | 71K | $1.08 |
| 2025-09-16 | Lettmann Jason | Buy | 21K | $1.07 |
| 2025-08-18 | Shantharam Harish | Buy | 75K | $0.78 |
| 2025-08-15 | Lettmann Jason | Sell | 2.4K | $0.64 |
| 2025-08-15 | Pinto Shelly | Sell | 611 | $0.64 |
| 2025-07-07 | Pinto Shelly | Sell | 2.0K | $0.45 |
| 2025-06-30 | Pinto Shelly | Sell | 1.5K | $0.43 |
| 2025-03-14 | Pinto Shelly | Grant | 3.0K | — |
| 2025-03-14 | Lettmann Jason | Grant | 42K | — |
| 2025-02-19 | Pinto Shelly | Sell | 550 | $1.15 |
| 2025-02-19 | Pons Jaume | Sell | 1.3K | $1.15 |
| 2025-02-19 | Lettmann Jason | Sell | 2.2K | $1.15 |
| 2025-01-06 | Pinto Shelly | Sell | 2.2K | $1.80 |
| 2024-12-30 | Pinto Shelly | Sell | 1.4K | $1.58 |
| 2024-12-30 | Pons Jaume | Sell | 11K | $1.58 |
All non-derivative Form 4 activity (SEC), newest first.
Notable events (8-K)
| Date | Items | |
|---|---|---|
| 2026-06-26 | Material agreement1.02Debt obligationExhibits | filing ↗ |
| 2026-06-11 | Shareholder vote | filing ↗ |
| 2026-05-08 | ResultsExhibits | filing ↗ |
| 2026-04-13 | Exec/director changeReg FDExhibits | filing ↗ |
| 2026-02-27 | ResultsExhibits | filing ↗ |
| 2026-01-30 | OtherExhibits | filing ↗ |
| 2026-01-30 | Material agreementOtherExhibits | filing ↗ |
| 2026-01-21 | Exec/director changeExhibits | filing ↗ |
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 8-K | 2026-06-26 | 2026-06-25 | 0001193125-26-285425 ↗ |
| 8-K | 2026-06-11 | 2026-06-10 | 0001193125-26-267472 ↗ |
| 10-Q | 2026-05-08 | 2026-03-31 | 0001193125-26-213399 ↗ |
| 8-K | 2026-05-08 | 2026-05-08 | 0001193125-26-213380 ↗ |
| 8-K | 2026-04-13 | 2026-04-13 | 0001193125-26-152050 ↗ |
| 10-K | 2026-03-09 | 2025-12-31 | 0001193125-26-098454 ↗ |
| 8-K | 2026-02-27 | 2026-02-27 | 0001193125-26-079342 ↗ |
| 8-K | 2026-01-30 | 2026-01-30 | 0001193125-26-030579 ↗ |
| 8-K | 2026-01-30 | 2026-01-30 | 0001193125-26-030561 ↗ |
| 8-K | 2026-01-21 | 2026-01-21 | 0001193125-26-018094 ↗ |
| 8-K | 2025-11-07 | 2025-11-07 | 0001193125-25-271112 ↗ |
| 10-Q | 2025-11-07 | 2025-09-30 | 0001193125-25-272281 ↗ |